BAXTER HEALTHCARE CORPORATION

Lobbying for BAXTER HEALTHCARE CORPORATION

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 16, 2025

Expenses

$390,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Medicare/Medicaid

Issues related to pharmaceutical pricing. Issues related to drug shortages.

Health Issues

Issues relating to drug pricing, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. Issues related to artificial intelligence technology in healthcare; issues related to Hurricane Helene. Issues around emergency preparedness and critical medical supplies.

Budget/Appropriations

Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.

Taxation/Internal Revenue Code

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies.

Trade (domestic/foreign)

None.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.